These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY. BMC Cancer; 2012 Oct 05; 12():452. PubMed ID: 23039099 [Abstract] [Full Text] [Related]
3. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues. Xuan SY, Xin YN, Chen H, Shi GJ, Guan HS, Li Y. World J Gastroenterol; 2007 Mar 28; 13(12):1870-4. PubMed ID: 17465484 [Abstract] [Full Text] [Related]
4. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. J Clin Gastroenterol; 1994 Oct 28; 19(3):222-6. PubMed ID: 7528758 [Abstract] [Full Text] [Related]
5. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. Lee DS, Huh K, Lee EH, Lee DH, Hong KS, Sung YC. J Gastroenterol Hepatol; 1997 Dec 28; 12(12):855-61. PubMed ID: 9504897 [Abstract] [Full Text] [Related]
6. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients. Higashi Y, Tada S, Miyase S, Hirota K, Imamura H, Kamio T, Suko H. Liver; 2002 Oct 28; 22(5):374-9. PubMed ID: 12390472 [Abstract] [Full Text] [Related]
9. HBV coinfection with HCV alters circulating Tfh cell distribution and impairs HCV neutralizing antibody responses. Wen B, Zhang J, Liu W, Tang P, Xie T, Huang L, Hu Y, Jin K, Zhang P, Liu Z, Niu L, Qu X. J Viral Hepat; 2019 Aug 28; 26(8):1002-1010. PubMed ID: 30972873 [Abstract] [Full Text] [Related]
10. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H. Int J Epidemiol; 1998 Aug 28; 27(4):574-8. PubMed ID: 9758109 [Abstract] [Full Text] [Related]
11. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, Kanwal F. Hepatology; 2014 Dec 28; 60(6):1871-8. PubMed ID: 25065513 [Abstract] [Full Text] [Related]
12. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K, Pal NS, Arora SK. Indian J Pathol Microbiol; 2006 Jul 28; 49(3):357-61. PubMed ID: 17001884 [Abstract] [Full Text] [Related]
13. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant. Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ. J Infect Dis; 2013 Apr 28; 207(7):1047-57. PubMed ID: 23300165 [Abstract] [Full Text] [Related]
14. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P. J Med Virol; 1997 Apr 28; 51(4):313-8. PubMed ID: 9093946 [Abstract] [Full Text] [Related]
15. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327 [Abstract] [Full Text] [Related]
16. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network. Chang IC, Huang SF, Chen PJ, Chen CL, Chen CL, Wu CC, Tsai CC, Lee PH, Chen MF, Lee CM, Yu HC, Lo GH, Yeh CT, Hong CC, Eng HL, Wang J, Tseng HH, Hsiao CH, Wu HI, Yen TC, Liaw YF. Medicine (Baltimore); 2016 Apr 01; 95(15):e3284. PubMed ID: 27082566 [Abstract] [Full Text] [Related]
17. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Su WW, Lin CL, Yang HC, Chen PJ, Chen DS, Liu CJ, Taiwan Liver-Net Consortium. Hepatology; 2013 Jun 01; 57(6):2135-42. PubMed ID: 23322699 [Abstract] [Full Text] [Related]
18. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus. Yu JW, Sun LJ, Zhao YH, Kang P, Gao J, Li SC. Liver Int; 2009 Nov 01; 29(10):1485-93. PubMed ID: 19602134 [Abstract] [Full Text] [Related]
19. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. J Med Virol; 2001 Jul 01; 64(3):350-5. PubMed ID: 11424125 [Abstract] [Full Text] [Related]
20. Etiological and molecular profile of hepatocellular cancer from India. Asim M, Sarma MP, Kar P. Int J Cancer; 2013 Jul 15; 133(2):437-45. PubMed ID: 23233429 [Abstract] [Full Text] [Related] Page: [Next] [New Search]